It mimics the GLP-1hormone that is released in the gastrointestinal tract in response to eating.One role of GLP-1 is to prompt the body to produce more insulin, which reducesblood glucose (sugar)
Self-injection products will play an increasingly valuable role in driving compliance, protecting high-risk patients, and reducing the need for clinic-based treatment. ApiJect: Responding to Demand for Equity & Supply Chain Shortages Global demand is rising for equitable access to medicine, including injectables
less research for telogen effluvium specifically, but biological plausibility is strong
The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, et al
For patients tired of GLP-1 medications Considering Weight Loss Surgery After GLP-1 Medications